THSD7A (thrombospondin type 1 domain containing 7A)

2017-08-01  

Identity

HGNC
LOCATION
7p21.3
LOCUSID
ALIAS
-
FUSION GENES

Other Information

Locus ID:

NCBI: 221981
MIM: 612249
HGNC: 22207
Ensembl: ENSG00000005108

Variants:

dbSNP: 221981
ClinVar: 221981
TCGA: ENSG00000005108
COSMIC: THSD7A

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000005108ENST00000423059Q9UPZ6
ENSG00000005108ENST00000617773A0A087WY08

Expression (GTEx)

0
5
10
15

Pathways

PathwaySourceExternal ID
Metabolism of proteinsREACTOMER-HSA-392499
Post-translational protein modificationREACTOMER-HSA-597592
O-linked glycosylationREACTOMER-HSA-5173105
O-glycosylation of TSR domain-containing proteinsREACTOMER-HSA-5173214
DiseaseREACTOMER-HSA-1643685
Diseases of glycosylationREACTOMER-HSA-3781865
Diseases associated with O-glycosylation of proteinsREACTOMER-HSA-3906995
Defective B3GALTL causes Peters-plus syndrome (PpS)REACTOMER-HSA-5083635

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
371570702023[Clinical Significance of Thrombospondin Type 1 Domain-Containing 7A and Neural Epidermal Growth Factor-Like 1 Protein in M-Type Phospholipase A2 Receptor-Negative Membranous Nephropathy].0
371570702023[Clinical Significance of Thrombospondin Type 1 Domain-Containing 7A and Neural Epidermal Growth Factor-Like 1 Protein in M-Type Phospholipase A2 Receptor-Negative Membranous Nephropathy].0
356706532022Comprehensively characterizing cellular changes and the expression of THSD7A and PLA2R1 under multiple in vitro models of podocyte injury.0
356706532022Comprehensively characterizing cellular changes and the expression of THSD7A and PLA2R1 under multiple in vitro models of podocyte injury.0
332497332021Renal expression of PLA2R, THSD7A, and IgG4 in patients with membranous nephropathy and correlation with clinical findings.8
340406022021Case Report: THSD7A-Positive Membranous Nephropathy Caused by Tislelizumab in a Lung Cancer Patient.16
332497332021Renal expression of PLA2R, THSD7A, and IgG4 in patients with membranous nephropathy and correlation with clinical findings.8
340406022021Case Report: THSD7A-Positive Membranous Nephropathy Caused by Tislelizumab in a Lung Cancer Patient.16
313954352020Autoantigens PLA2R and THSD7A in membranous nephropathy share a common epitope motif in the N-terminal domain.11
329356002020Clinical characteristics of thrombospondin type-1 domain-containing 7A-associated membranous nephropathy.3
313954352020Autoantigens PLA2R and THSD7A in membranous nephropathy share a common epitope motif in the N-terminal domain.11
329356002020Clinical characteristics of thrombospondin type-1 domain-containing 7A-associated membranous nephropathy.3
305205312019Structure and function insights garnered from in silico modeling of the thrombospondin type-1 domain-containing 7A antigen.6
314436442019Expression of THSD7A in neoplasm tissues and its relationship with proteinuria.15
305205312019Structure and function insights garnered from in silico modeling of the thrombospondin type-1 domain-containing 7A antigen.6

Citation

Dessen P

THSD7A (thrombospondin type 1 domain containing 7A)

Atlas Genet Cytogenet Oncol Haematol. 2017-08-01

Online version: http://atlasgeneticsoncology.org/gene/56989